Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Sieper J, Kivitz A, van Tubergen A, Deodhar A, Szegvari B, Nurminen T, Landewé R.
PMID: 27200870
Value Health. 2014 Nov;17(7):A385-6. doi: 10.1016/j.jval.2014.08.2643. Epub 2014 Oct 26.

No abstract available.

Cite
Sieper J, Kivitz A, van Tubergen A, et al. Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study. Value Health. 2014;17(7):A385-6doi: 10.1016/j.jval.2014.08.2643.
Sieper, J., Kivitz, A., van Tubergen, A., Deodhar, A., Szegvari, B., Nurminen, T., & Landewé, R. (2014). Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A385-6. https://doi.org/10.1016/j.jval.2014.08.2643
Sieper, J, et al. "Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A385-6. doi: https://doi.org/10.1016/j.jval.2014.08.2643
Sieper J, Kivitz A, van Tubergen A, Deodhar A, Szegvari B, Nurminen T, Landewé R. Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa Study. Value Health. 2014 Nov;17(7):A385-6. doi: 10.1016/j.jval.2014.08.2643. Epub 2014 Oct 26. PMID: 27200870.
Copy Download .nbib Format: NLM
Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.

Annals of the rheumatic diseases

Ramiro S, Stolwijk C, van Tubergen A.
PMID: 26063810
Ann Rheum Dis. 2015 Jul;74(7):1482. doi: 10.1136/annrheumdis-2013-204055corr1.

No abstract available.

Cite
Ramiro S, Stolwijk C, van Tubergen A. Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74(7):1482doi: 10.1136/annrheumdis-2013-204055corr1.
Ramiro, S., Stolwijk, C., & van Tubergen, A. (2015). Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Annals of the rheumatic diseases, 74(7), 1482. https://doi.org/10.1136/annrheumdis-2013-204055corr1
Ramiro, S, et al. "Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study." Annals of the rheumatic diseases vol. 74,7 (2015): 1482. doi: https://doi.org/10.1136/annrheumdis-2013-204055corr1
Ramiro S, Stolwijk C, van Tubergen A. Correction. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015 Jul;74(7):1482. doi: 10.1136/annrheumdis-2013-204055corr1. PMID: 26063810.
Copy Download .nbib Format: NLM
Irreconcilable differences? Ethnic intermarriage and divorce in the Netherlands, 1995-2008.

Social science research

Smith S, Maas I, van Tubergen F.
PMID: 23017922
Soc Sci Res. 2012 Sep;41(5):1126-37. doi: 10.1016/j.ssresearch.2012.02.004. Epub 2012 Feb 27.

This study uses population data of the Netherlands (municipality registers) between 1995 and 2008 to describe and explain the occurrence of divorce among recently newlywed interethnic and mono-ethnic couples (N=116,745). In line with homogamy theory, divorce risks are higher...

Cite
Smith S, Maas I, van Tubergen F. Irreconcilable differences? Ethnic intermarriage and divorce in the Netherlands, 1995-2008. Soc Sci Res. 2012;41(5):1126-37doi: 10.1016/j.ssresearch.2012.02.004.
Smith, S., Maas, I., & van Tubergen, F. (2012). Irreconcilable differences? Ethnic intermarriage and divorce in the Netherlands, 1995-2008. Social science research, 41(5), 1126-37. https://doi.org/10.1016/j.ssresearch.2012.02.004
Smith, Sanne, et al. "Irreconcilable differences? Ethnic intermarriage and divorce in the Netherlands, 1995-2008." Social science research vol. 41,5 (2012): 1126-37. doi: https://doi.org/10.1016/j.ssresearch.2012.02.004
Smith S, Maas I, van Tubergen F. Irreconcilable differences? Ethnic intermarriage and divorce in the Netherlands, 1995-2008. Soc Sci Res. 2012 Sep;41(5):1126-37. doi: 10.1016/j.ssresearch.2012.02.004. Epub 2012 Feb 27. PMID: 23017922.
Copy Download .nbib Format: NLM
Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life.

RMD open

Imkamp M, Lima Passos V, Boonen A, Arends S, Dougados M, Landewé R, Ramiro S, Van den Bosch F, van der Heijde D, Wink FR, Spoorenberg A, van Tubergen A.
PMID: 30487997
RMD Open. 2018 Nov 14;4(2):e000755. doi: 10.1136/rmdopen-2018-000755. eCollection 2018.

OBJECTIVE: The goal of managing axial spondyloarthritis (axSpA) is to improve and maintain patients' health-related quality of life (HRQoL), mainly through targeting towards low disease activity. Here, we aim to gain insight into the joint evolution of HRQoL and...

Cite
Imkamp M, Lima Passos V, Boonen A, et al. Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life. RMD Open. 2018;4(2):e000755doi: 10.1136/rmdopen-2018-000755.
Imkamp, M., Lima Passos, V., Boonen, A., Arends, S., Dougados, M., Landewé, R., Ramiro, S., Van den Bosch, F., van der Heijde, D., Wink, F. R., Spoorenberg, A., & van Tubergen, A. (2018). Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life. RMD open, 4(2), e000755. https://doi.org/10.1136/rmdopen-2018-000755
Imkamp, Maike, et al. "Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life." RMD open vol. 4,2 (2018): e000755. doi: https://doi.org/10.1136/rmdopen-2018-000755
Imkamp M, Lima Passos V, Boonen A, Arends S, Dougados M, Landewé R, Ramiro S, Van den Bosch F, van der Heijde D, Wink FR, Spoorenberg A, van Tubergen A. Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life. RMD Open. 2018 Nov 14;4(2):e000755. doi: 10.1136/rmdopen-2018-000755. eCollection 2018. PMID: 30487997; PMCID: PMC6241970.
Copy Download .nbib Format: NLM
Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

RMD open

Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A.
PMID: 30564453
RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018.

OBJECTIVE: To investigate the occurrence of ankylosing spondylitis (AS)-related sick leave (SL) over 6 12 years and explore factors predicting first and recurrent SL.METHODS: Data from employed patients from the Outcome in Ankylosing Spondylitis International Study were used. At...

Cite
Webers C, Ramiro S, Landewé R, et al. Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. RMD Open. 2018;4(2):e000766doi: 10.1136/rmdopen-2018-000766.
Webers, C., Ramiro, S., Landewé, R., van der Heijde, D., van den Bosch, F., Dougados, M., van Tubergen, A., & Boonen, A. (2018). Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. RMD open, 4(2), e000766. https://doi.org/10.1136/rmdopen-2018-000766
Webers, Casper, et al. "Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study." RMD open vol. 4,2 (2018): e000766. doi: https://doi.org/10.1136/rmdopen-2018-000766
Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A. Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018. PMID: 30564453; PMCID: PMC6269643.
Copy Download .nbib Format: NLM
Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort.

Arthritis care & research

de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, van Schaardenburg DJ, van Gaalen FA, van Tubergen AM, Weel AEAM, Landewé RBM, Baeten DLP, van de Sande MGH.
PMID: 34219406
Arthritis Care Res (Hoboken). 2021 Jul 05; doi: 10.1002/acr.24743. Epub 2021 Jul 05.

OBJECTIVES: As first-degree relatives (FDRs) of HLA-B27-positive axial spondyloarthritis (axSpA) patients have an increased risk of developing axSpA, the objectives were 1) to evaluate presence of highly specific imaging features as well as clinical signs of SpA at baseline...

Cite
de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, et al. Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24743.
de Jong, H. M. Y., de Winter, J. J. H., van der Horst-Bruinsma, I. E., van Schaardenburg, D. J., van Gaalen, F. A., van Tubergen, A. M., Weel, A. E. A. M., Landewé, R. B. M., Baeten, D. L. P., & van de Sande, M. G. H. (2021). Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis care & research, . https://doi.org/10.1002/acr.24743
de Jong, Henriëtte M Y, et al. "Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24743
de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, van Schaardenburg DJ, van Gaalen FA, van Tubergen AM, Weel AEAM, Landewé RBM, Baeten DLP, van de Sande MGH. Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis Care Res (Hoboken). 2021 Jul 05; doi: 10.1002/acr.24743. Epub 2021 Jul 05. PMID: 34219406.
Copy Download .nbib Format: NLM
Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction.

RMD open

Baraliakos X, Heldmann F, van den Bosch F, Burmester G, Gaston H, van der Horst-Bruinsma IE, Krause A, Schmidt R, Schneider M, Sieper J, Andermann B, van Tubergen A, Witt M, Braun J.
PMID: 27493791
RMD Open. 2016 Jul 19;2(2):e000272. doi: 10.1136/rmdopen-2016-000272. eCollection 2016.

OBJECTIVE: To analyse the treatment outcome of patients with ankylosing spondylitis (AS) in the European AS infliximab cohort (EASIC) study after a total period of 8 years with specific focus on dosage and the duration of intervals between infliximab...

Cite
Baraliakos X, Heldmann F, van den Bosch F, et al. Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction. RMD Open. 2016;2(2):e000272doi: 10.1136/rmdopen-2016-000272.
Baraliakos, X., Heldmann, F., van den Bosch, F., Burmester, G., Gaston, H., van der Horst-Bruinsma, I. E., Krause, A., Schmidt, R., Schneider, M., Sieper, J., Andermann, B., van Tubergen, A., Witt, M., & Braun, J. (2016). Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction. RMD open, 2(2), e000272. https://doi.org/10.1136/rmdopen-2016-000272
Baraliakos, X, et al. "Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction." RMD open vol. 2,2 (2016): e000272. doi: https://doi.org/10.1136/rmdopen-2016-000272
Baraliakos X, Heldmann F, van den Bosch F, Burmester G, Gaston H, van der Horst-Bruinsma IE, Krause A, Schmidt R, Schneider M, Sieper J, Andermann B, van Tubergen A, Witt M, Braun J. Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction. RMD Open. 2016 Jul 19;2(2):e000272. doi: 10.1136/rmdopen-2016-000272. eCollection 2016. PMID: 27493791; PMCID: PMC4964174.
Copy Download .nbib Format: NLM
GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study.

BJGP open

van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A.
PMID: 30564647
BJGP Open. 2017 Jan 09;1(1):bjgpopen17X100689. doi: 10.3399/bjgpopen17X100689.

BACKGROUND: Timely recognition and referral of patients with spondyloarthritis (SpA) is challenging due to the frequent unawareness of the clinical picture.AIM: To identify clinical assessment patterns of GPs and GP-residents when facing a patient suspected of having SpA, and...

Cite
van Onna M, Gorter S, Maiburg B, et al. GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study. BJGP Open. 2017;1(1):bjgpopen17X100689doi: 10.3399/bjgpopen17X100689.
van Onna, M., Gorter, S., Maiburg, B., Waagenaar, G., & van Tubergen, A. (2017). GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study. BJGP open, 1(1), bjgpopen17X100689. https://doi.org/10.3399/bjgpopen17X100689
van Onna, Marloes, et al. "GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study." BJGP open vol. 1,1 (2017): bjgpopen17X100689. doi: https://doi.org/10.3399/bjgpopen17X100689
van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A. GPs' patterns of clinical assessment when faced with a patient suspected for spondyloarthritis: a prospective educational intervention study. BJGP Open. 2017 Jan 09;1(1):bjgpopen17X100689. doi: 10.3399/bjgpopen17X100689. PMID: 30564647; PMCID: PMC6172669.
Copy Download .nbib Format: NLM
Treat-to-target in axial spondyloarthritis: an observational study in daily practice.

Rheumatology (Oxford, England)

Beckers E, Boonen A, Webers C, Ten Klooster P, Vonkeman H, Efdé M, van Tubergen A.
PMID: 34175950
Rheumatology (Oxford). 2021 Jun 27; doi: 10.1093/rheumatology/keab516. Epub 2021 Jun 27.

OBJECTIVES: To evaluate the extent to which internationally agreed treat-to-target (T2T) recommendations were applied in clinical practice in patients with axial spondyloarthritis (axSpA).METHODS: Data were used from a web-based patient registry for monitoring SpA in daily practice in the...

Cite
Beckers E, Boonen A, Webers C, et al. Treat-to-target in axial spondyloarthritis: an observational study in daily practice. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab516.
Beckers, E., Boonen, A., Webers, C., Ten Klooster, P., Vonkeman, H., Efdé, M., & van Tubergen, A. (2021). Treat-to-target in axial spondyloarthritis: an observational study in daily practice. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab516
Beckers, Esther, et al. "Treat-to-target in axial spondyloarthritis: an observational study in daily practice." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab516
Beckers E, Boonen A, Webers C, Ten Klooster P, Vonkeman H, Efdé M, van Tubergen A. Treat-to-target in axial spondyloarthritis: an observational study in daily practice. Rheumatology (Oxford). 2021 Jun 27; doi: 10.1093/rheumatology/keab516. Epub 2021 Jun 27. PMID: 34175950.
Copy Download .nbib Format: NLM
Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy

van Wissen MAT, Teuwen MMH, van den Ende CHM, Vliet Vlieland TPM, den Broeder AA, van den Hout WB, Peter WF, van Schaardenburg D, van Tubergen AM, Gademan MGJ, van Weely SFE.
PMID: 34780107
Physiother Res Int. 2021 Nov 15;e1933. doi: 10.1002/pri.1933. Epub 2021 Nov 15.

OBJECTIVES: Research on effectiveness and cost-effectiveness of longstanding exercise therapy in patients with axial SpondyloArthritis (axSpA) or Rheumatoid Arthritis (RA) is scarce, and mainly concerned patients with a relatively favorable health status. We aim to evaluate the effectiveness and...

Cite
van Wissen MAT, Teuwen MMH, van den Ende CHM, et al. Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiother Res Int. 2021;e1933doi: 10.1002/pri.1933.
van Wissen, M. A. T., Teuwen, M. M. H., van den Ende, C. H. M., Vliet Vlieland, T. P. M., den Broeder, A. A., van den Hout, W. B., Peter, W. F., van Schaardenburg, D., van Tubergen, A. M., Gademan, M. G. J., & van Weely, S. F. E. (2021). Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiotherapy research international : the journal for researchers and clinicians in physical therapy, e1933. https://doi.org/10.1002/pri.1933
van Wissen, Maria A T, et al. "Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials." Physiotherapy research international : the journal for researchers and clinicians in physical therapy vol. (2021): e1933. doi: https://doi.org/10.1002/pri.1933
van Wissen MAT, Teuwen MMH, van den Ende CHM, Vliet Vlieland TPM, den Broeder AA, van den Hout WB, Peter WF, van Schaardenburg D, van Tubergen AM, Gademan MGJ, van Weely SFE. Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiother Res Int. 2021 Nov 15;e1933. doi: 10.1002/pri.1933. Epub 2021 Nov 15. PMID: 34780107.
Copy Download .nbib Format: NLM
Heat Inactivation of Catalase in Deuterium Oxide.

Science (New York, N.Y.)

Guild WR, VAN Tubergen RP.
PMID: 17740547
Science. 1957 May 10;125(3254):939. doi: 10.1126/science.125.3254.939.

No abstract available.

Cite
Guild WR, VAN Tubergen RP. Heat Inactivation of Catalase in Deuterium Oxide. Science. 1957;125(3254):939doi: 10.1126/science.125.3254.939.
Guild, W. R., & VAN Tubergen, R. P. (1957). Heat Inactivation of Catalase in Deuterium Oxide. Science (New York, N.Y.), 125(3254), 939. https://doi.org/10.1126/science.125.3254.939
Guild, W R, and VAN Tubergen, R P. "Heat Inactivation of Catalase in Deuterium Oxide." Science (New York, N.Y.) vol. 125,3254 (1957): 939. doi: https://doi.org/10.1126/science.125.3254.939
Guild WR, VAN Tubergen RP. Heat Inactivation of Catalase in Deuterium Oxide. Science. 1957 May 10;125(3254):939. doi: 10.1126/science.125.3254.939. PMID: 17740547.
Copy Download .nbib Format: NLM
Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors.

RMD open

Essers I, van Tubergen A, Heldmann F, Baraliakos X, Braun J, Kiltz U, Boonen A.
PMID: 26629367
RMD Open. 2015 Nov 17;1(1):e000164. doi: 10.1136/rmdopen-2015-000164. eCollection 2015.

OBJECTIVE: To investigate whether patients with ankylosing spondylitis (AS) adapt to their disease, using the 'then-test'.METHODS: Data from patients participating in the AS Study for Evaluation of Recombinant Infliximab Therapy (ASSERT) and continuing in the European AS Infliximab Cohort...

Cite
Essers I, van Tubergen A, Heldmann F, et al. Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors. RMD Open. 2015;1(1):e000164doi: 10.1136/rmdopen-2015-000164.
Essers, I., van Tubergen, A., Heldmann, F., Baraliakos, X., Braun, J., Kiltz, U., & Boonen, A. (2015). Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors. RMD open, 1(1), e000164. https://doi.org/10.1136/rmdopen-2015-000164
Essers, Ivette, et al. "Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors." RMD open vol. 1,1 (2015): e000164. doi: https://doi.org/10.1136/rmdopen-2015-000164
Essers I, van Tubergen A, Heldmann F, Baraliakos X, Braun J, Kiltz U, Boonen A. Do patients with ankylosing spondylitis adapt to their disease? Evidence from a 'then-test' in patients treated with TNF inhibitors. RMD Open. 2015 Nov 17;1(1):e000164. doi: 10.1136/rmdopen-2015-000164. eCollection 2015. PMID: 26629367; PMCID: PMC4654100.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries